Search research articles
Contact Us
Filters
Showing results (81-90 of 152) with videos related to
Page
of 16
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 23, 2021
Arterial Hypertension in a 10-Year-Old Girl
Alina Meeser, Bodo B Beck, Martin Dübbers, et al.
BMC Cancer
|
June 18, 2022
Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma - Data from the prospective, multicenter phase III HD16 trial
Lutz van Heek, Colin Stuka, Helen Kaul, et al.
British Journal of Haematology
|
December 20, 2021
Impact of bone marrow involvement on early positron emission tomography response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphoma
Stefanie Kreissl, Conrad-Amadeus Voltin, Helen Kaul, et al.
The Cochrane Database of Systematic Reviews
|
January 14, 2020
Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies
Angela Aldin, Lisa Umlauff, Lise J Estcourt, et al.
Molecular Imaging and Biology
|
May 28, 2015
Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer
Markus Dietlein, Carsten Kobe, Georg Kuhnert, et al.
The Cochrane Database of Systematic Reviews
|
September 17, 2019
Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies
Angela Aldin, Lisa Umlauff, Lise J Estcourt, et al.
Leukemia & Lymphoma
|
June 25, 2019
Volumetric assessment of mediastinal lymphoma masses in Hodgkin lymphoma
Christian Baues, Helen Görgen, Robert Semrau, et al.
EJNMMI Research
|
July 27, 2019
Biodistribution and radiation dosimetry of [<sup>18</sup>F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate cancer
Melanie Hohberg, Carsten Kobe, Philipp Krapf, et al.
Hematological Oncology
|
March 21, 2022
Phase II study of fixed-duration single-agent ibrutinib in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group
Dennis A Eichenauer, Ina Bühnen, Annette Plütschow, et al.
Hemasphere
|
August 27, 2025
Serum TARC dynamics during anti-PD1-based first-line Hodgkin lymphoma treatment: An analysis from the GHSG NIVAHL trial
Wouter J Plattel, Sophie Teesink, Lydia Visser, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 152) with videos related to
Sort By:
Page
of 16
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 23, 2021
Arterial Hypertension in a 10-Year-Old Girl
Alina Meeser, Bodo B Beck, Martin Dübbers, et al.
BMC Cancer
|
June 18, 2022
Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma - Data from the prospective, multicenter phase III HD16 trial
Lutz van Heek, Colin Stuka, Helen Kaul, et al.
British Journal of Haematology
|
December 20, 2021
Impact of bone marrow involvement on early positron emission tomography response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphoma
Stefanie Kreissl, Conrad-Amadeus Voltin, Helen Kaul, et al.
The Cochrane Database of Systematic Reviews
|
January 14, 2020
Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies
Angela Aldin, Lisa Umlauff, Lise J Estcourt, et al.
Molecular Imaging and Biology
|
May 28, 2015
Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer
Markus Dietlein, Carsten Kobe, Georg Kuhnert, et al.
The Cochrane Database of Systematic Reviews
|
September 17, 2019
Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies
Angela Aldin, Lisa Umlauff, Lise J Estcourt, et al.
Leukemia & Lymphoma
|
June 25, 2019
Volumetric assessment of mediastinal lymphoma masses in Hodgkin lymphoma
Christian Baues, Helen Görgen, Robert Semrau, et al.
EJNMMI Research
|
July 27, 2019
Biodistribution and radiation dosimetry of [<sup>18</sup>F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate cancer
Melanie Hohberg, Carsten Kobe, Philipp Krapf, et al.
Hematological Oncology
|
March 21, 2022
Phase II study of fixed-duration single-agent ibrutinib in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group
Dennis A Eichenauer, Ina Bühnen, Annette Plütschow, et al.
Hemasphere
|
August 27, 2025
Serum TARC dynamics during anti-PD1-based first-line Hodgkin lymphoma treatment: An analysis from the GHSG NIVAHL trial
Wouter J Plattel, Sophie Teesink, Lydia Visser, et al.
Page
of 16